Results 231 to 240 of about 9,346,254 (401)

Gradient Solvent Replacement‐Mediated Formation of High‐Strength Hydrogel‐Forming Microneedle for Long‐Term Drug Delivery

Advanced Science, EarlyView.
A high‐strength pH‐responsive hydrogel‐forming microneedle integrates gradient solvent replacement to enhance the mechanical properties of the acrylonitrile‐acrylic acid copolymer network, ensuring robust transdermal penetration and long‐term drug release.
Hui Li, Fengzhen Meng, Chengwei Hu, Zhiyun Wu, Liuzhi Hao, Caijun Sun, Lijing Fang, Fan Pan, Shaoquan Bian, Huipeng Li, Mingjun Li, Bo Liu, Xiaoli Zhao   +12 more
wiley   +1 more source

Data-Driven Subtypes of Parkinson Disease Based on Dopamine Responsiveness. [PDF]

CNS Neurosci Ther
Wang JY, Zeng GL, Tang RT, Luo HT, Song YL, Zhou YY, Huang JF, Zhu SG, Zhang DL, Liu DN, Liu RP, Huang SS, Yuan CX, Zhu JH, Zhang X.   +14 more
europepmc   +1 more source

Linkage of Parkinsonism and Alzheimer's disease with Lewy body pathology to chromosome 12 [PDF]

, 2002
William K. Scott, Jeffery M. Vance, Jonathan L. Haines, Margaret A. Pericak‐Vance   +3 more
openalex   +1 more source

Generation of Neural Organoids and Their Application in Disease Modeling and Regenerative Medicine

Advanced Science, EarlyView.
Neural organoids provide a versatile platform for neurological research. Advances in organoid technology have partially achieved human neural tissue complexity in terms of tissue structure, cell diversity, and neural signaling, offering insights into neural disorders and regenerative strategies. Technology advances from biomaterials, bio‐manufacturing,
Ruiqi Huang, Feng Gao, Liqun Yu, Haokun Chen, Rongrong Zhu   +4 more
wiley   +1 more source

The modifying effect of mutant LRRK2 on mutant GBA1-associated Parkinson disease. [PDF]

Hum Mol Genet
Serebryany-Piavsky V, Egulsky L, Manoim-Wolkovitz JE, Anis S, Hassin-Baer S, Parnas M, Horowitz M.   +6 more
europepmc   +1 more source

Neuroleptics and family history of Parkinson diseases: case report

, 2001
G Theodoulou, Gerald Milner, A. Jumaian
openalex   +1 more source

769. Gene Therapy for Preventing Neural Degeneration Using Hepatocute Growth Factor: Basic Research with Experimental Model of Parkinsons Disease [PDF]

, 2002

openalex   +1 more source

RPL6 Interacts with HMGCS1 to Stabilize HIF‐1α by Promoting Cholesterol Production in Hepatocellular Carcinoma

Advanced Science, EarlyView.
The study found that RPL6 is frequently upregulated in HCC tissues with extrahepatic metastasis. Elevated RPL6 bound to and increased the stability of HMGCS1 mRNA, thereby enhancing intracellular cholesterol levels. Subsequently, increased cholesterol promotes cancer metastasis in HCC by stabilizing HIF‐1α protein.
Minli Yang, Shengtao Cheng, Huiying Gu, Shan Zhong, Dapeng Zhang, Xin He, Weixian Chen, Haijun Deng, Jihua Ren, Peng Chen, Ming Tan, Hui Zhang, Fan Li, Zhenzhen Zhang, Yuan Hu, Juan Chen   +15 more
wiley   +1 more source

Impact of pimavanserin on prescribing practices in parkinson disease. [PDF]

Clin Park Relat Disord
Pham Nguyen TP, Le V, Weintraub D, Willis AW.   +3 more
europepmc   +1 more source

Pleiotropic effects of variants in dementia genes in Parkinson disease [PDF]

, 2018
Benitez, Bruno A, Budde, John, Cooper, Breanna, Cruchaga, Carlos, David, Albert A, Diez-Fairen, Monica, Dube, Umber, Fernandez, Maria V, Ibanez, Laura, Ortega-Cubero, Sara, Pastor, Pau, Perlmutter, Joel S   +11 more
core   +2 more sources